Venus Remedies Limited (NSE:VENUSREM)

Venus Remedies Revenue

In the fiscal year ending March 31, 2026, Venus Remedies had annual revenue of 7.70B INR with 18.79% growth. Venus Remedies had revenue of 2.59B in the quarter ending March 31, 2026, with 33.05% growth.

• Revenue: 7.70B
• Revenue Growth: +18.79%
• P/S Ratio: 3.06
• Revenue / Employee: 5.93M
• Employees: 1,298
• Market Cap: 23.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	7.70B	1.22B	18.79%
Mar 31, 2025	6.48B	464.37M	7.72%
Mar 31, 2024	6.01B	459.40M	8.27%
Mar 31, 2023	5.56B	-446.71M	-7.44%
Mar 31, 2022	6.00B	520.57M	9.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error